Ptc Therapeutics (PTCT) Return on Capital Employed (2013 - 2026)
Ptc Therapeutics' (PTCT) quarterly Return on Capital Employed came in at 2.98% in Q1 2026, down 4797.0% year-on-year from 0.06% in Q1 2025, and down 106.19% quarter-over-quarter from 48.09% in Q4 2025.
Ptc Therapeutics (PTCT) Return on Capital Employed (2013 - 2026) Analysis & Trends
Ptc Therapeutics' Return on Capital Employed history runs 14 years deep, the most recent figure standing at 2.98% for Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 4797.0% year-over-year to 2.98% in Q1 2026; TTM through Mar 2026 was 2.98%, a 4797.0% decrease from a year earlier, with the FY2025 full-year figure at 65.01%, up 8983.0% from the prior year.
- Return on Capital Employed fell to 2.98% in Q1 2026 per PTCT's latest filing, from 48.09% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 48.09% in Q4 2025 and bottomed at 80.02% in Q3 2023.
- The 5-year median for Return on Capital Employed is 26.06% (2022), against an average of 14.88%.
- Across the five-year window, Return on Capital Employed slumped 5390 bps in 2023 and soared 7396 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 36.23% in 2022, then slipped by 24 bps to 45.09% in 2023, then soared by 44 bps to 25.37% in 2024, then soared by 290 bps to 48.09% in 2025, then sank by 106 bps to 2.98% in 2026.
- Per Business Quant, the three latest PTCT Return on Capital Employed figures stand at 2.98% (Q1 2026), 48.09% (Q4 2025), and 43.77% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Ptc Therapeutics | 6.47 Bn | 4.58 Bn | 244.52 Mn | -2.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.98% |
| Dec 31, 2025 | 48.09% |
| Sep 30, 2025 | 43.77% |
| Jun 30, 2025 | 35.62% |
| Mar 31, 2025 | 45.00% |
| Dec 31, 2024 | -25.37% |
| Sep 30, 2024 | -10.59% |
| Jun 30, 2024 | -15.93% |
| Mar 31, 2024 | -28.97% |
| Dec 31, 2023 | -45.09% |
| Sep 30, 2023 | -80.02% |
| Jun 30, 2023 | -59.74% |
| Mar 31, 2023 | -39.36% |
| Dec 31, 2022 | -36.23% |
| Sep 30, 2022 | -26.12% |
| Jun 30, 2022 | -28.89% |
| Mar 31, 2022 | -26.06% |
| Dec 31, 2021 | -25.59% |
| Sep 30, 2021 | -24.63% |
| Jun 30, 2021 | -19.40% |